{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T14:26:03Z","timestamp":1775312763887,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.hrthm.2023.01.032","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T21:45:39Z","timestamp":1675115139000},"page":"709-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies"],"prefix":"10.1016","volume":"20","author":[{"given":"Marissa J.","family":"Stutzman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maengjo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Tester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Giudicessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8011-3333","authenticated-orcid":false,"given":"Michael J.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2023.01.032_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-020-0188-7","article-title":"Inherited cardiac arrhythmias","volume":"6","author":"Schwartz","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hrthm.2023.01.032_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ccep.2017.07.005","article-title":"Channelopathies as causes of sudden cardiac death","volume":"9","author":"Schwartz","year":"2017","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hrthm.2023.01.032_bib3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2023.01.032_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacep.2018.03.006","article-title":"Clinical spectrum of SCN5A mutations: long QT syndrome, Brugada syndrome, and cardiomyopathy","volume":"4","author":"Wilde","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.14797\/mdcj-10-1-29","article-title":"Genetics of long QT syndrome","volume":"10","author":"Tester","year":"2014","journal-title":"Methodist DeBakey Cardiovasc J"},{"key":"10.1016\/j.hrthm.2023.01.032_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jacc.2017.05.046","article-title":"Contemporary outcomes in patients with long QT syndrome","volume":"70","author":"Rohatgi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","article-title":"Influence of the Genotype on the clinical course of the long-QT syndrome","volume":"339","author":"Zareba","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2023.01.032_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004370","article-title":"Ranolazine for congenital long-QT syndrome type III: experimental and long-term clinical data","volume":"9","author":"Chorin","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib9","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.96.6.2038","article-title":"Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome","volume":"96","author":"Shimizu","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.01.032_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.hrthm.2021.09.016","article-title":"Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome","volume":"19","author":"Bains","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2023.01.032_bib11","unstructured":"Neves R, Bains S, Bos JM, MacIntyre C, Giudicessi JR, Ackerman MJ. Precision therapy in congenital long QT syndrome. Trends Cardiovasc Med 2022 Jun 27;S1050-1738(22)00090-00091."},{"key":"10.1016\/j.hrthm.2023.01.032_bib12","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients","volume":"116","author":"Ruan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.01.032_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00232-004-0702-y","article-title":"Interactions of local anesthetics with voltage-gated Na+ channels","volume":"201","author":"Nau","year":"2004","journal-title":"J Membr Biol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib15","first-page":"118","article-title":"MTSET modification of D4S6 cysteines stabilize the fast inactivated state of Nav1.5 sodium channels","volume":"6","author":"O'Leary","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.hrcr.2016.10.001","article-title":"Complexity of ranolazine and phenytoin use in an infant with long QT syndrome type 3","volume":"3","author":"Tan","year":"2017","journal-title":"HeartRhythm Case Rep"},{"key":"10.1016\/j.hrthm.2023.01.032_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1006\/jmcc.2002.2040","article-title":"Late Na currents affected by alpha subunit isoform and beta1 subunit co-expression in HEK293 cells","volume":"34","author":"Valdivia","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib18","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.704627","article-title":"Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome","volume":"116","author":"Van Norstrand","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2023.01.032_bib19","article-title":"Development of a patient-specific p.D85N-potassium voltage-gated channel subfamily E member 1-induced pluripotent stem cell-derived cardiomyocyte model for drug-induced long QT syndrome","volume":"14","author":"Kim","year":"2021","journal-title":"Circ Genom\u00a0Precis Med"},{"key":"10.1016\/j.hrthm.2023.01.032_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.hrthm.2023.01.032_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1113\/jphysiol.2007.134262","article-title":"Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels","volume":"582","author":"Sheets","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1085\/jgp.201611668","article-title":"Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants","volume":"149","author":"Tikhonov","year":"2017","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijcard.2007.05.060","article-title":"Mutation-specific effects of lidocaine in Brugada syndrome","volume":"121","author":"Clancy","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/mol.118.114025","article-title":"Mexiletine block of voltage-gated sodium channels: isoform- and state-dependent drug\u2013pore interactions","volume":"95","author":"Nakagawa","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib25","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1152\/jn.1997.77.6.3021","article-title":"Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin","volume":"77","author":"Segal","year":"1997","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.hrthm.2023.01.032_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-209521","article-title":"Phenytoin as an effective treatment for polymorphic ventricular tachycardia due to QT prolongation in a patient with multiple drug intolerances","volume":"2015","author":"Yager","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.hrthm.2023.01.032_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/mol.110.064683","article-title":"Molecular model of anticonvulsant drug binding to the voltage-gated sodium channel inner pore","volume":"78","author":"Lipkind","year":"2010","journal-title":"Mol Pharmacol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527123001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527123001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:58:53Z","timestamp":1761548333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527123001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1547527123001157"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.01.032","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2023.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}